Olema Insider Sells $8 Million in Shares After 300% Stock Surge

Olema Pharmaceuticals is a biotechnology company specializing in therapies for women's cancers, with a particular emphasis on breast cancer. The company's strategy centers on advancing its proprietary drug candidate, OP-1250, through clinical development to address significant unmet medical needs.How does the sale value compare to recent stock performance? The weighted average sale price of around $29.73 per share was 7.5% above the Dec. 19 market close of $27.93, amid a one-year total return of 326.50% as ...